The quality of evidence is downgraded by suspected publication bias (larger effect noted in small studies).
A Cochrane review [Abstract] 1 included 17 studies with a total of 1 586 subjects. All studies enrolled children at increased risk of AOM. The majority of the studies were of high quality. Long-term antibiotics (mainly amoxycillin or sulfisoxazole) reduced any episode of AOM (RR 0.65, 95% CI 0.53 to 0.79, statistical heterogeneity I2 =68%; 14 studies, n=1 461) and number of episodes of AOM (incidence rate ratio (IRR) 0.51, 95% CI 0.39 to 0.66, statistical heterogeneity I2 =73%; 13 studies, n=1 327), NNT = 5 to prevent one child experiencing AOM whilst on long-term treatment. Antibiotics prevented 1.5 episodes of AOM for every 12 months of treatment per child. Long-term antibiotics were associated with a statistically non-significant increase in adverse events (RR 1.99, 95% CI 0.25 to 15.89, statistical heterogeneity I2 =53%; 12 studies, n=817).
Comment: The possibility for and effects of the development of antibiotic resistance if antibiotic prophylaxis is widely practised is a major concern.
Primary/Secondary Keywords